City of Hope Natera Minimal Residual Disease Test Value Called Into Question by City of Hope CRC Patient Data Premium Based on the results of their new study, City of Hope researchers advised doctors against overreliance on Natera's Signatera assays for recurrence monitoring. Aiming to Cut Unnecessary Surgeries, City of Hope Team to Commercialize CRC Metastasis Dx Signature Premium The team will use the reverse-transcriptase quantitative PCR test, which uses a milliliter of a patient's blood, to curb unneeded radical colon cancer surgeries. TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine Premium The liquid biopsy method analyzes fragment ends within recurrently protected regions in cell-free DNA from a patient's urine sample. Genetic Study of Skin Pigmentation in African Americans Uncovers Links to Vitamin D Deficiency Starting with a genome-wide association study focused on skin pigmentation, investigators identified genetic variants with additional ties to vitamin D levels. Stupid Strong Awards City of Hope $125K for Gastric Cancer Liquid Biopsy Research The team will launch a Phase II study to validate early-stage gastric cancer micro-RNA biomarkers and eventually develop liquid biopsy tests. May 29, 2020 City of Hope Team Develops ICP-MS Method for Multiplexed Protein Quantitation Premium Aug 27, 2019 NHGRI Awards $3M Under Genomic Innovator Program Aug 9, 2019 TGen-Led Team Prepares to Validate 'TARDIS' Blood-Based Cancer Monitoring Method Premium Feb 1, 2019 Precision Medicine Platform for Oncology Aims to Streamline Molecular Testing, Therapy Decision-Making Premium Sep 21, 2017 DxTerity, City of Hope Partner to Develop Blood Test for Radiation Therapy Response Dec 29, 2016 Younger, Older Prostate Cancer Cases Marked by Distinct Expression Patterns Nov 30, 2016 City of Hope, Translational Genomics Research Institute Form Personalized Medicine Alliance Oct 7, 2015 NIDDKD Awards $2.2M to City of Hope for Epigenetic Studies into Type 1 Diabetes Jun 2, 2014 ASCO Talk Highlights Genetic Contributors to Later Life Complications in Pediatric Cancer Patients May 30, 2014 Sangamo, City of Hope Get $5.6M Grant for ZFP Tx for HIV/AIDS Mar 5, 2013 IP Watch: Glaxo Group, Hitachi, City of Hope, Esoterix, Penn State, Others Win US Patents Premium Jul 24, 2012 IP Watch: City of Hope, Gen-Probe, Promega, Roche, and DNA Genotek Win US Patents Premium May 10, 2012 IP Watch: LLNL, Lab21, NetBio, Life Tech, City of Hope, and U of Missouri Win US Patents Premium Apr 4, 2012 IP Watch: Fluidigm, GeneNews, Pioneer Hi-Bred, Dupont, Others Win US Patents Premium Feb 23, 2012 GigaGen Developing Droplet PCR System for Single-Cell Sequencing, Will Target Immune Applications Premium Oct 4, 2011 GnuBio Targets 1K-Base Reads for Commercial Launch of $50K Sequencer Premium Apr 7, 2011 IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Apr 7, 2011 Premium Mar 30, 2011 IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Mar 30, 2011 Premium Mar 17, 2011 City of Hope Preps for Second Study with Expressed RNAi AIDS Treatment Premium Jan 6, 2011 In 2010, RNAi Moves into the Mainstream, microRNAs Continue to Garner Interest Premium Load More Breaking News Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.